Jeffrey J. Tosoian MD, MPH
Assistant Professor of Urology, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TNJeffrey J. Tosoian, MD, MPH, is an Assistant Professor of Urology at the Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center. He completed medical school and urology residency at Johns Hopkins, where he obtained an MPH in epidemiological and biostatistical methods for clinical research. He then completed a translational research and clinical fellowship in urologic oncology at the University of Michigan. Dr. Tosoian’s research is focused on the development and clinical application of diagnostic and prognostic tools, including blood-, urine-, and tissue-based biomarkers, to guide detection and management of genitourinary cancers.
Disclosures
Dr. Tosoian is a co-founder of LynxDx, Inc.
Recent Contributions to PracticeUpdate:
- Diagnosis and Treatment of Oligometastatic Prostate Cancer
- Use of Active Surveillance for Localized Prostate Cancer Over the Last Two Decades
- Long-Term Results of Active Surveillance in the Göteborg Prostate Cancer Screening Trial
- ASCO GU 2016: Dr. Matthew Cooperberg's Best of Journals 2015
- Advanced Prostate Cancer PracticeChanger in 2015: Updated Histological Grading
- Advanced Prostate Cancer PracticeChanger in 2015: Neoadjuvant Therapy for Metastatic Hormone-Sensitive Disease
- Late Prostatic Bed Recurrence
- 55 Year-Old Man Presenting in Urinary Retention Found to Have Very High Risk Disease
- Prostate Genetic Score and Risk of Prostate Cancer
- Healthy 56 Year-Old Man With High-Volume Gleason Score 8 Prostate Cancer